Concepedia

Pauline M. van Helden

PM

Statistics

Publications

13

Citations

487

H-Index

12

Active since

2002

Affiliations

AIMM Therapeutics (Netherlands)(Current)

Sanquin

Amsterdam UMC Location University of Amsterdam

Baxter (Austria)

University Medical Center Utrecht

Pauline M. van Helden is an author at AIMM Therapeutics (Netherlands) specializing in life sciences, hematology, and immunology.

ORCID

Publications per year

2002–2019

13

Publications

13

IgG subclasses of anti‐FVIII antibodies during immune tolerance induction in patients with hemophilia A

Pauline M. van Helden, H. Marijke van den Berg, Samantha C. Gouw et al. · British Journal of Haematology · 2008 · 95 citations · Full text

, , +6

CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice

Katharina Nora Steinitz, Pauline M. van Helden, Brigitte Binder et al. · Blood · 2012 · 73 citations · Full text

, , +16

The modified FACS calcein AM retention assay: A high throughput flow cytometer based method to measure cytotoxicity

Marijn A. Gillissen, Etsuko Yasuda, Greta de Jong et al. · Journal of Immunological Methods · 2016 · 49 citations · Full text

, , +15

Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes

Taylor M. Triolo, Alexandra Fouts, Laura Pyle et al. · Diabetes Care · 2018 · 39 citations · Full text

, , +17

Selective Requirement for CD40-CD154 in Drug-Induced Type 1 Versus Type 2 Responses to Trinitrophenyl-Ovalbumin

Stefan Nierkens, Pauline M. van Helden, Marianne Bol et al. · The Journal of Immunology · 2002 · 33 citations · Full text

, , +17

1–5 of 13